Key facts
- This page summarizes Richard K. Prins's Form 4 filing for IGC Pharma, Inc. (IGC).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 06 Apr 2026, 16:02.
Richard K. Prins - 01 Apr 2026 Form 4 Insider Report for IGC Pharma, Inc. (IGC)
- Reporting relationship
- Director
- Issuer ticker
- IGC
- Reported as of
- 01 Apr 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Apr 2026, 16:02:50 UTC
- Prior SEC filing
- 20 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Richard Prins
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Richard K. Prins filed Form 4 for IGC Pharma, Inc. (IGC) on 06 Apr 2026.
Change
- Previous filing in this sequence was filed on 20 Jan 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001047579
Primary reporting owner
PRINS RICHARD K
- Relationship
- Director
- Address
- 10224 FALLS ROAD, POTOMAC
- Signature
- /s/ Richard Prins
- Signature date
- 06 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IGC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +100,000
- Change %
- +7.3%
- Price
- $0.000000*
- Shares after
- 1,471,251
- Date
- 01 Apr 2026
- Ownership
- Direct
- Footnotes
- F1
IGC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +70,000
- Change %
- +4.8%
- Price
- $0.000000*
- Shares after
- 1,541,251
- Date
- 01 Apr 2026
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IGC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -100,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 01 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- Footnotes
- F1, F3
IGC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -70,000
- Change %
- -50%
- Price
- $0.000000*
- Shares after
- 70,000
- Date
- 01 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 70,000
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.
Footnote F2
On March 13, 2024, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2025.
Footnote F3
Each restricted stock unit represents a right to receive one share of IGC common stock.